Species Differences in Blood-Brain Barrier Transport of Three Positron Emission Tomography Radioligands with Emphasis on P-Glycoprotein Transport

10.1016/j.neuropharm.2006.07.038

10.1038/sj.bjp.0706283

10.1016/S1053-8119(03)00405-1

10.1016/S0028-3908(99)00182-3

1994, Eur J Nucl Med, 21, 937

1984, Am J Physiol, 246, R277, 10.1152/ajpcell.1984.246.3.C277

10.1002/jps.20658

2005, J Nucl Med, 46, 1384

10.1002/(SICI)1098-2396(200004)36:1<66::AID-SYN7>3.0.CO;2-J

2003, Eur J Nucl Med Mol Imaging, 30, 912, 10.1007/s00259-003-1171-8

10.1016/j.biopsych.2005.03.029

10.1002/syn.20363

10.1002/syn.20059

1999, Cancer Res, 59, 2411

1999, J Pharmacol Exp Ther, 289, 1084

10.1124/jpet.105.097931

10.1093/nar/gkl996

10.1002/jps.20686

2008, Eur J Nucl Med Mol Imaging, 5, 5

10.1021/jm800510m

10.1124/jpet.105.088328

1991, J Nucl Med, 32, 2266

10.1002/syn.20348

10.1016/j.neuroimage.2003.09.058

10.1016/j.nucmedbio.2004.06.007

10.1016/j.biopsych.2006.07.003

10.1124/dmd.31.10.1251

10.1016/S0014-2999(00)00752-4

2000, J Nucl Med, 41, 1830

2003, J Cereb Blood Flow Metab, 23, 985, 10.1097/01.WCB.0000074092.59115.23

2003, Behav Pharmacol, 14, 457

10.1016/j.clpt.2005.01.022

10.1016/S0969-8051(00)00212-2

10.1002/jps.20787

Syvänen S (2003) Evaluation of plasma-to-brain PK-models for an NK1-receptor antagonist based on positron emission tomography investigations. Master's thesis, Uppsala University, Uppsala, Sweden.

10.1016/j.neuroimage.2006.05.047

10.1186/1471-2342-7-6

10.1002/jps.21359

10.1016/S0969-8051(99)00022-0

10.1111/j.1574-6968.1999.tb13575.x

10.1016/S0006-8993(99)02018-1

10.1006/nimg.2001.0910

10.1021/mp050034j

2001, J Pharmacol Exp Ther, 296, 723

10.1002/syn.20327

10.1002/syn.20392

10.2967/jnumed.107.047308